DCI Blog

The DCI Blog highlights patient stories, DCI research, the accomplishments of DCI faculty and staff, and fundraising events.

1 - 11 of 11 posts

Ines Batinic Haberle hold up a vial of BMX-001 in her lab

Dr. Ines Batinic Haberle in her lab with a vial of BMX-001, a synthetic form of superoxide dismutase.

News Mention

Duke Drug Improves Survival in Advanced Brain Cancer Patients

February 07, 2024

Duke University School of Medicine

Article

Searching For & Finding Cancers' Achilles Heels: The Eighth Annual DCI Scientific Retreat Was One for the Books

January 07, 2024

Duke Cancer Institute Blog

Man stands at a Duke University School of Medicine podium facing woman smiling. "Duke Cancer Institute 50th Anniversary: Celebrating 50 years of exceptional cancer care" is projected on the screen behind them.

Duke Cancer Institute Executive Director Michael B. Kastan, MD, PhD, presents medical student Priya Alagesan, BS, with the Robert and Barbara Bell Award For Basic Science Cancer Research at the 2022 DCI Scientific Retreat.

Article

At DCI’s 9th Annual Scientific Retreat, the Learning(s) Was Infectious

January 07, 2024

Duke Cancer Institute Blog

News Mention

Duke Increases Equitable Access to Pediatric Brain Tumor Care

December 18, 2023

Clinical Practice Today

a table of posters made by kids and adults for World Cancer Day 2022

A table of posters made by kids and adults for World Cancer Day, Feb. 4, 2022.

Article

New Moonshot Initiative: Improving Pediatric Brain Cancer Outcomes in Africa

August 15, 2023

Duke Cancer Institute Blog

News Mention

Recurrent GBM Brain Tumors with Few Mutations Respond Best to Immunotherapy

August 14, 2023

Duke Health Newsroom

News Mention

Poliovirus Therapy for Recurrent Glioblastoma Has Three-Year Survival Rate of 21 Percent

August 14, 2023

Duke Health Newsroom

News Mention

Yan Receives International Prize for Translational Neuroscience

August 13, 2023

Duke Neurosurgery

In a room with cabinets, two men in masks face each other; one seated in a white t-shirt and the other standing in a lab coat with stethoscope.

Terence Wong, MD, PhD, right, meets with a patient before his PSMA PET/CT scan. Duke is a leader in this type of imaging, which is used in combination with a radiotracer to identify if there's a druggable molecular target. (A version of this photo originally appeared in a Duke Health article in February 2022: "PSMA PET/CT Scan Improves Prostate Cancer Detection and Treatment")

Article